Real-World Analysis of Adverse Events Associated with CAR T-Cell Therapy Among Adults Age ≥65 Years
Marjorie E Zettler, et al.
This large-scale post-marketing report of CAR T-cell therapy associated AEs provides real-world evidence for use of CAR T-cell therapy in patients ≥65 and reports patterns of AEs observed based on age.
